AI Risks for Government Contractors: Navigating Disputes and Litigation
Navigating GSA Audits Compliance Strategies and Best Practices
What’s the Tea in L&E? Is There Such a Thing as a Purely Verbal Counseling?
California Employment News: Synthesizing Evidence in a Workplace Investigation (Part 3)
Pamela Para on Effective Investigations in Healthcare
Jannica Houben and Katarzyna Golonka on Complex Investigations
Ashley Coselli and Daniel Wendt on Difficult Anti-Corruption Due Diligence Projects
Practical Training for Project Managers & Supervisors Two-Part Webinar Series: Part Two
Legal Use Case 7 Part II: The Prescription
[Webinar] Common Massachusetts Cannabis Business Compliance Pitfalls
Department of Labor Imposes Additional Requirement on Employer-Provided Health Services
Compliance Perspectives: Compliance Officer Liability Risk
Navigating the New Normal: Risk Management and Legal Considerations for Real Estate Companies
Search Warrant Protocol: Stop a Bad Day from Getting Worse [More with McGlinchey Ep. 6]
Maximizing PPP Loan Forgiveness | Webinar
Nota Bene Episode 76: The Impact of COVID-19 on Force Majeure Clauses in Business Contracts
Podcast: Questions & Concerns About Documentation: A Conversation with Colin Adams, M-III Partners
Podcast: Credit Funds: Replacing LIBOR – Steps To Consider Taking Now
Cybersecurity in the investment management industry
This Week in FCPA-Episode 80, The Last Jedi Edition
Friday, July 12, 2024, the EU published the new EU Artificial Intelligence Regulation, which is first EU AI Regulation worldwide setting requirements concerning safety and free movement of goods and services using AI...more
US and EU Life Sciences Law firms Fieldfisher & Gardner Law recently held a CLE event in Silicon Valley covering Healthcare Compliance, Data Privacy and Regulatory hot topics for MedTech and Pharma companies. Discussion...more
After having dealt with the issue when software may be considered a medical device according to its intended purpose (in part 2) and the implications of the new risk classification regime (in part 3), in this part 4 of our...more
A new guidance document from the FDA lists considerations and suggested steps to reduce the likelihood of cybersecurity breaches in medical devices....more